API
< Back to all clusters
[BUSINESS] · 2 sources

started · updated

Evosep announces strategic partnerships to standardize proteomics workflows

Evosep has announced two major strategic developments aimed at standardizing proteomics workflows for pharmaceutical and research applications.

In a collaboration with Mass Dynamics, the companies intend to standardize the LC-MS proteomics workflow from sample preparation through to quality control and interpretation. This partnership seeks to reduce variability in proteomics, a critical factor for biomarker discovery, target validation, and drug development. By combining Evosep’s automated sample preparation with Mass Dynamics’ collaborative software, the goal is to provide reproducible results across large cohorts and multiple laboratory sites.

Additionally, Evosep has entered into a reseller agreement with Thermo Fisher Scientific. Under this agreement, Thermo Fisher Scientific will offer the Evosep Eno separation platform as part of its mass spectrometry solutions portfolio. This move leverages Thermo Fisher’s global commercial reach to expand access to Evosep’s technology, facilitating the implementation of scalable and robust proteomics workflows in laboratories worldwide.

Entities

Thermo Fisher Scientific